• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Theravance Inc. (THRX)

    -NasdaqGS
    17.92 Up 0.46(2.63%) Apr 24, 4:00PM EDT
    |After Hours : 17.92 0.00 (0.00%) Apr 24, 4:03PM EDT
    Add to Portfolio
    Prev Close:17.46
    Open:17.57
    Bid:14.00 x 100
    Ask:18.45 x 300
    1y Target Est:23.86
    Beta:2.68
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:16.84 - 18.00
    52wk Range:10.58 - 31.80
    Volume:880,235
    Avg Vol (3m):922,824
    Market Cap:2.09B
    P/E (ttm):N/A
    EPS (ttm):-1.50
    Div & Yield:1.00 (6.60%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    THRXUp 2.63%2.09B
    AZNDown 1.83%90.68B
    PFEDown 0.25%216.57B

    Key Statistics

    Forward P/E (1 yr):41.67
    P/S (ttm):241.46
    Ex-Dividend Date:10-Mar-15

    Analysts

    Annual EPS Est (Dec-15) :-0.12
    Quarterly EPS Est (Mar-15) :-0.08
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.87

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback